| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/03/2004 | WO2004033418A3 Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists |
| 06/03/2004 | WO2004022542A3 Substituted 1,2,3,4-tetrahydroquinoline derivatives |
| 06/03/2004 | WO2004018419A3 Benzimidazole quinolinones and uses thereof |
| 06/03/2004 | WO2004014868A3 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 06/03/2004 | WO2004009549A3 Piperidines useful for the treatment of central nervous system disorders |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | WO2003048153A8 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers |
| 06/03/2004 | US20040106833 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/03/2004 | US20040106802 Novel compounds and therapeutic uses thereof |
| 06/03/2004 | US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission |
| 06/03/2004 | US20040106796 cyclization of a 3-amidyl-4-amino-pyrazole compound with n-hydroxy-5-[(4-methylpiperazin-1-yl)sulfonyl]benzenecarboximidamidine compound; anti-impotency drugs |
| 06/03/2004 | US20040106792 Biphenyl compound |
| 06/03/2004 | US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 06/03/2004 | US20040106652 such as (2S)-3,3-dimethyl-1-[2-(5-phenylpentanoyl) pyrrolidinyl]pentane-1,2-dione which has affinity for immunophilin; for treatment of neurological disorders/neurodegenerative diseases; nerve growth factors; FK binding proteins |
| 06/03/2004 | US20040106650 4-Pyrrolidino-phenyl-benzyl ether derivatives |
| 06/03/2004 | US20040106645 Antagonists of melanin concentrating hormone receptor |
| 06/03/2004 | US20040106635 Spiroisoquinoline compound, a method for preparing the same and an intermediate thereof |
| 06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/2004 | US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106625 Therapeutic agents useful for treating pain |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106621 3-Heterocyclic benzylamide derivatives as potassium channel openers |
| 06/03/2004 | US20040106620 5-Substituted-2-arylpyrazines |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant |
| 06/03/2004 | US20040106612 Selective inhibitor of cyclooxygenase-2 used as an antipyretic, an analgesic, and an antiinflammatory agent, with reduced side effects. |
| 06/03/2004 | US20040106608 Novel imidazole compounds as transforming growth factor (TGF) inhibitors |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106600 N-substituted piperidine derivatives as serotonin receptor agents |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106598 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/03/2004 | US20040106594 Phenyl heterocyclyl ethers |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | US20040106521 Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 06/03/2004 | US20040106520 A pplying to plants; controlling weeds |
| 06/03/2004 | US20040106519 Herbicidal composition |
| 06/03/2004 | DE10254596A1 Indolderivate Indole derivatives |
| 06/03/2004 | DE10254506A1 N-Aryl-4,5-diaminopyrazole und diese Verbindungen enthaltende Färbemittel N-aryl-4,5-diaminopyrazole and colorants comprising these compounds |
| 06/03/2004 | DE10254092A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| 06/03/2004 | DE10252665A1 4-Aminomethyl-1-aryl-cyclohexylamin-Derivate 4-aminomethyl-1-aryl-cyclohexylamine derivatives |
| 06/03/2004 | CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors |
| 06/03/2004 | CA2506735A1 Indole derivatives as somatostatin agonists or antagonists |
| 06/03/2004 | CA2506503A1 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 06/03/2004 | CA2506297A1 Pyridine n-oxide compounds as phosphodiesterase 4 inhibitors |
| 06/03/2004 | CA2506025A1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 06/03/2004 | CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 06/03/2004 | CA2505789A1 Diaminotriazoles useful as inhibitors of protein kinases |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | CA2499133A1 Pyrazine compounds as crf modulators |
| 06/02/2004 | EP1424340A1 Metal complex photosensitizers and photo-electrochemical cell |
| 06/02/2004 | EP1424337A1 4-hydroxy derivatives of 5,6,9,10-tetrahydro-10-((2-methyl-1h-imidazol-1-yl)methyl)-4h-pyrido-(3,2,1-jk)-carbazol-11(8h)-one |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424334A1 Quinazolinone derivative |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423379A1 Ortho-substituted aryl amides for controlling invertebrate pests |
| 06/02/2004 | EP1423378A1 Aminopyrrole compounds as antiinflammatory agents |
| 06/02/2004 | EP1423373A2 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
| 06/02/2004 | EP1423363A1 Oral antidiabetic agents |
| 06/02/2004 | EP1423362A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 06/02/2004 | EP1423122A2 Compositions and methods relating to novel benzodiazepine compounds and targets thereof |
| 06/02/2004 | EP1423121A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 06/02/2004 | EP1423120A1 2h-phthalazin-1-ones and methods for use thereof |
| 06/02/2004 | EP1423115A2 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1230249B1 Transition metal complexes with bidentate ligand having an imidazole ring |
| 06/02/2004 | EP1182202B1 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 06/02/2004 | CN1501962A Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
| 06/02/2004 | CN1501917A Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501796A Treatment of type 2 diabetes mellitus using inhibitors of dipeptidyl peptidase IV |
| 06/02/2004 | CN1501773A Liquid formulations for dernal application in treatment of parasitic insects in animals |
| 06/02/2004 | CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives |
| 06/02/2004 | CN1152031C Isoquinoline derivatives with angiogenesis inhibiting activity |
| 06/02/2004 | CN1152030C Novel heterocyclic compounds |
| 06/02/2004 | CN1152029C Quinolonecarboxylic acid derivatives and salts thereof |
| 06/02/2004 | CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1152015C Piperazine devivatives and preparing method thereof |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/02/2004 | CN1151789C Use of aryl (or heteroaryl) pyrrolyl methanol derivatives |
| 06/01/2004 | US6743919 2-aroylimidazole compounds for treating cancer |
| 06/01/2004 | US6743914 Using tertiary amine catalyst |
| 06/01/2004 | US6743818 Treating anxiety, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse, cognitive disorders, psychoses, depression and mood disorders |
| 06/01/2004 | US6743817 Substituted fused pyrroleimines and pyrazoleimines |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743809 Indole Derivatives useful for the treatment of CNS disorders |
| 06/01/2004 | US6743808 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) tetrahydropyridines or piperazines |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743806 Tetrazolylalkoxy-dihydrocarbostyril compound; treatment of an acute cerebral infarction; 6-(4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril; 6-substituted-2-quinolinone derivatives |
| 06/01/2004 | US6743805 Treating vascular proliferative disorders |
| 06/01/2004 | US6743804 Quinoline derivatives as NK3 antagonists |